Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unconventional therapy in multiple sclerosis.

Jaume Sastre-Garriga1, Elvira Munteis, Jordi Río

  • 1Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. jsastre@hg.vhebron.es

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Spinal cord reserve is associated with multi-dimensional clinical resilience in multiple sclerosis.

Journal of neurology·2026
Same author

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Brain : a journal of neurology·2026
Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026
Same author

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

JAMA network open·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Unconventional therapy use is common among multiple sclerosis (MS) patients in Europe. Patients with higher disability and dissatisfaction with conventional medicine are more likely to use these therapies.

Area of Science:

  • Neurology
  • Complementary and Alternative Medicine

Background:

  • Growing use of unconventional therapies in Western countries.
  • Limited European data on frequency and reasons for use in multiple sclerosis (MS) patients.

Purpose of the Study:

  • Assess the frequency of unconventional therapy use in MS patients.
  • Explore clinical variables associated with this use.

Main Methods:

  • Structured questionnaires administered to 380 MS patients at two Barcelona clinics.
  • Collected data on demographics, education, income, and therapy use.
  • Assessed satisfaction with conventional medicine for MS.

Main Results:

  • 41% of MS patients reported using unconventional therapies in the past year.

Related Experiment Videos

  • Higher Expanded Disability Status Scale (EDSS) scores were associated with therapy use (mean EDSS 4.43 vs 3.48).
  • Lower satisfaction with conventional medicine (general and MS-specific) correlated with increased use.

    • Conclusions:

    • Unconventional therapy use is prevalent in MS patients.
    • High disability levels and dissatisfaction with conventional treatments are key associated factors.